Education
About Us
Working with TipRanks
Follow Us
Envista Holdings Corp (NVST)
NYSE:NVST
NVST Stock Chart & Stats
$22.00
-$0.72(-3.69%)
At close: 4:00 PM EST
$22.00
-$0.72(-3.69%)
Day’s Range― - ―
52-Week Range$14.22 - $22.68
Previous CloseN/A
Volume757.64K
Average Volume (3M)2.11M
Market Cap
$3.62B
Enterprise Value$3.85B
Total Cash (Recent Filing)$1.13B
Total Debt (Recent Filing)$1.60B
Price to Earnings (P/E)263.0
Beta0.92
Next Earnings
Feb 11, 2026EPS Estimate
0.32Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.32
Shares Outstanding164,426,240
10 Day Avg. Volume2,887,914
30 Day Avg. Volume2,107,342
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)1.13
Price to Sales (P/S)1.32
P/FCF Ratio10.97
Enterprise Value/Market Cap1.06
Enterprise Value/Revenue1.47
Enterprise Value/Gross Profit2.65
Enterprise Value/Ebitda11.26
Forecast
1Y Price Target
$27.22Price Target Upside23.73% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering13
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Market OpportunitiesNVST could see more meaningful margin progression if the developed market premium implant and aligner market unlock as it will be a mix benefit to margins.
Profitability And Market PositionEnvista is set to exit 2025 in a much better footing than it entered the year with Spark turning to profitability, implant growth relative to the market improving in NA, and solid Spark growth in a challenging market.
Revenue And Earnings GrowthNVST beat consensus revenue and EPS in 3Q25 and management raised the lower end of its 2025 revenue and EPS guidance while maintaining its EBITDA margin guidance.
Bears Say
Interest Rates And Capital ExpenditureHigh interest rates and significant leverage have caused DSOs and practices to pull back on elective capital expenditures, prioritizing only essential equipment purchases.
Macroeconomic ChallengesMacro headwinds continue to create real pressures to patient flow and willingness to spend, especially for higher-cost and/or more elective procedures.
Valuation ConcernsDespite improved execution, the current stock price already reflects much of this improvement, making further rating upgrades challenging.
Envista Holdings News
NVST FAQ
What was Envista Holdings Corp’s price range in the past 12 months?
Envista Holdings Corp lowest stock price was $14.22 and its highest was $22.68 in the past 12 months.
What is Envista Holdings Corp’s market cap?
Envista Holdings Corp’s market cap is $3.62B.
When is Envista Holdings Corp’s upcoming earnings report date?
Envista Holdings Corp’s upcoming earnings report date is Feb 11, 2026 which is in 46 days.
How were Envista Holdings Corp’s earnings last quarter?
Envista Holdings Corp released its earnings results on Oct 29, 2025. The company reported $0.32 earnings per share for the quarter, beating the consensus estimate of $0.276 by $0.044.
Is Envista Holdings Corp overvalued?
According to Wall Street analysts Envista Holdings Corp’s price is currently Undervalued.
Does Envista Holdings Corp pay dividends?
Envista Holdings Corp does not currently pay dividends.
What is Envista Holdings Corp’s EPS estimate?
Envista Holdings Corp’s EPS estimate is 0.32.
How many shares outstanding does Envista Holdings Corp have?
Envista Holdings Corp has 164,426,240 shares outstanding.
What happened to Envista Holdings Corp’s price movement after its last earnings report?
Envista Holdings Corp reported an EPS of $0.32 in its last earnings report, beating expectations of $0.276. Following the earnings report the stock price went down -0.399%.
Which hedge fund is a major shareholder of Envista Holdings Corp?
Currently, no hedge funds are holding shares in NVST
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Envista Holdings Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$27.22 (23.73% Upside)
$27.22 (23.73% Upside)
Blogger Sentiment
Bullish
NVST Sentiment 100%
Sector Average 68%
Sector Average 68%
Hedge Fund Trend
Decreased
By 1.5M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.1%
Last 30 Days ▼ 6.3%
Last 30 Days ▼ 6.3%
Technicals
SMA
Positive
20 days / 200 days
Momentum
16.09%
12-Months-Change
Fundamentals
Return on Equity
0.50%
Trailing 12-Months
Asset Growth
2.39%
Trailing 12-Months
Company Description
Envista Holdings Corp
Envista Holdings Corp. manufactures and markets dental products for diagnosing, treating and preventing dental conditions. The company is headquartered in Brea, California and currently employs 12,800 full-time employees. The firm provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone. The firm operates through two segments: Specialty Products & Technologies, and Equipment & Consumables. Its Specialty Products & Technologies segment develops, manufactures and markets dental implant systems, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. Its Equipment & Consumables segment develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems; treatment units and other dental practice equipment; endodontic systems and related consumables; restorative materials and instruments, rotary burs, impression materials, bonding agents and cements and infection prevention products.
NVST Company Deck
NVST Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call for Envista Holdings highlighted strong financial performance and growth across several business segments. The company achieved significant milestones in its Spark aligner business and raised its full-year guidance. However, challenges like tariff costs and uncertainties in the China market due to potential VBP impacts were noted. Overall, the positives in revenue growth, market share gains, and operational efficiency improvements outweigh the negatives.View all NVST earnings summariesNVST Revenue Breakdown
63.99% Specialty Products & Technologies
36.01% Equipment & Consumables
NVST Stock 12 Month Forecast
Average Price Target
$27.22
▲(23.73% Upside)
Technical Analysis
DENTSPLY SIRONA
―
Disc Medicine
―
Clover Health Investments
―
AbCellera Biologics
―
Bausch + Lomb Corporation
―
Ownership Overview
Currently, No data available
---